News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncotarget | Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD)

News

December 6, 2022
PRESS RELEASE: On December 6, 2022, a new research paper was published in Oncotarget, entitled, “Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD).” continue reading »

Genes & Cancer | CDK4: a master regulator of the cell cycle and its role in cancer

Genes & Cancer

December 2, 2022
PRESS RELEASE: A new review was published in Genes & Cancer on August 25, 2022, entitled, “CDK4: a master regulator of the cell cycle and its role in cancer.” continue reading »

Oncotarget | Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis

News

December 1, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on November 22, 2022, entitled, “Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis.” continue reading »

Aging | Glutaminase inhibitors rejuvenate human skin via clearance of senescent cells: a study using a mouse/human chimeric model

Aging

November 30, 2022
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 14, Issue 22, entitled, “Glutaminase inhibitors rejuvenate human skin via clearance of senescent cells: a study using a mouse/human chimeric model.” continue reading »

Oncotarget | Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more

News

November 29, 2022
A new review was published in Oncotarget's Volume 13 on November 17, 2022, entitled, “Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more.” continue reading »